TCG Crossover Management as of Sept. 30, 2022
Portfolio Holdings for TCG Crossover Management
TCG Crossover Management holds 21 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iveric Bio Comm | 20.9 | $70M | 3.9M | 17.94 | |
| Cogent Biosciences Comm (COGT) | 15.6 | $52M | 3.5M | 14.92 | |
| Geron Corp Comm (GERN) | 8.5 | $28M | 12M | 2.34 | |
| Viridian Therapeutics Comm (VRDN) | 7.2 | $24M | 1.2M | 20.51 | |
| Silence Therapeutics Adrs (SLN) | 6.3 | $21M | 2.1M | 10.03 | |
| Cymabay Therapeutics Comm | 6.2 | $21M | 5.9M | 3.50 | |
| Kura Oncology Comm (KURA) | 5.5 | $18M | 1.3M | 13.66 | |
| Aclaris Therapeutics Comm (ACRS) | 5.4 | $18M | 1.1M | 15.74 | |
| Aerovate Therapeutics Comm (AVTE) | 4.8 | $16M | 960k | 16.58 | |
| Entrada Therapeutics Comm (TRDA) | 3.0 | $10M | 642k | 15.76 | |
| Allakos Comm (ALLK) | 3.0 | $10M | 1.6M | 6.12 | |
| Akouos Comm | 2.7 | $9.1M | 1.4M | 6.76 | |
| Tyra Biosciences Comm (TYRA) | 2.5 | $8.3M | 946k | 8.79 | |
| Moonlake Immunotherapeutics Comm (MLTX) | 2.3 | $7.8M | 1.0M | 7.76 | |
| Merus Bv Comm (MRUS) | 1.8 | $6.0M | 300k | 20.03 | |
| Tango Therapeutics Comm (TNGX) | 1.3 | $4.2M | 1.2M | 3.62 | |
| Magenta Therapeutics Comm | 0.9 | $3.0M | 2.1M | 1.41 | |
| Zai Lab Ltd- Adrs (ZLAB) | 0.7 | $2.5M | 73k | 34.20 | |
| Madrigal Pharmaceuticals Comm (MDGL) | 0.6 | $2.0M | 30k | 65.00 | |
| Alpine Immune Sciences Comm | 0.5 | $1.8M | 255k | 7.20 | |
| Elevation Oncology Comm (ELEV) | 0.2 | $627k | 555k | 1.13 |
